Center for iPS Cell Research Application of Kyoto University and Takeda Pharmaceutical Company Limited announced today that they will work together to develop clinical applications of induced pluripotent stem cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy.
from The Medical News http://ift.tt/1DOc9gn
from The Medical News http://ift.tt/1DOc9gn
No comments:
Post a Comment